Seeking Alpha

Regeneron Pharmaceuticals (REGN): Q3 EPS of $1.89 beats by $0.93. Revenue of $428M (+315% Y/Y)...

Regeneron Pharmaceuticals (REGN): Q3 EPS of $1.89 beats by $0.93. Revenue of $428M (+315% Y/Y) beats by $79M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)